Overview

The global market for veterinary medicine remains highly consolidated in nature, with major global players dominating the landscape. While exact share percentages shift annually, the top ten companies operating in the global veterinary drugs market are estimated to hold a share well over 70% of the total market as of 2025.
The rising commercial potential of the market and increasingly lucrative opportunities, particularly in rapidly growing areas like companion animal health and emerging economies are the key factors projected to enhance the level of competition among the key players in the next few years.

According to the latest market research, the global market for veterinary medicina has experienced significant acceleration in growth. While the market was worth US$17.2 billion in 2015, its valuation has expanded dramatically. The market size is estimated to have reached between US$52.76 billion and US$56.68 billion in 2025, representing a substantial increase from the US$26.7 billion estimated for 2024 in earlier reports. The market is currently exhibiting a strong Compound Annual Growth Rate (CAGR) of 6.07% to 7.43% in the forecast period (2025–2032/2034). This accelerated growth is largely driven by the pervasive trend of pet humanization and increased expenditure on companion animal health.